Dr. Reddy's Laboratories Limited (RDDA) — Financial Flexibility Index
Dr. Reddy's Laboratories Limited (RDDA) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of €18.23 Billion (operating CF €10.91 Billion minus capex €7.32 Billion) represents 0% of total liabilities (€187.14 Billion). Also explore RDDA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dr. Reddy's Laboratories Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Dr. Reddy's Laboratories Limited across 9 annual periods. Check RDDA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Dr. Reddy's Laboratories Limited. For the full company profile including market capitalisation, see Dr. Reddy's Laboratories Limited (RDDA) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.52x | €80.83 Billion | €46.43 Billion | €155.82 Billion | ▼ -23.9% |
| 2024 | 0.68x | €72.87 Billion | €45.43 Billion | €106.97 Billion | ▼ -21.1% |
| 2023 | 0.86x | €77.74 Billion | €58.88 Billion | €89.99 Billion | ▲ +114.4% |
| 2022 | 0.40x | €42.77 Billion | €28.11 Billion | €106.13 Billion | ▼ -19.7% |
| 2021 | 0.50x | €45.44 Billion | €35.70 Billion | €90.51 Billion | ▲ +11.8% |
| 2020 | 0.45x | €34.69 Billion | €29.84 Billion | €77.25 Billion | ▲ +7.3% |
| 2019 | 0.42x | €35.66 Billion | €28.70 Billion | €85.23 Billion | ▲ +51.8% |
| 2018 | 0.28x | €27.32 Billion | €18.03 Billion | €99.14 Billion | ▼ -21.9% |
| 2017 | 0.35x | €33.79 Billion | €21.51 Billion | €95.78 Billion | — |